Viewing Study NCT00148668


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2026-02-22 @ 4:13 PM
Study NCT ID: NCT00148668
Status: COMPLETED
Last Update Posted: 2013-04-09
First Post: 2005-09-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
Sponsor: Eric Winer, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER-2 Positive Breast Cancer View
None herceptin View
None navelbine View
None taxotere View
None carboplatin View
None Early stage Breast Cancer View